Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

69116 1519310944HCLSReviewSerbiaFebruary2018.pdf
Energy Boardroom

Novartis and Roche now have France eyeing competition issues

12.03.2014 / Fierce Pharma

Efforts to steer doctors away from off-label use of cancer drug Avastin in favor of the pricier Lucentis for treating sight issues have gotten Swiss drugmakers Roche and Novartis fined by the anticompetition authority in Italy, where prosecutors are also taking a look, and now French regulators say they are in the midst of a probe of their own.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: